I am a
Home I AM A Search Login

Papers of the Week


Health Psychol Res



Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia.


Han AH, Burroughs CR, Falgoust EP, Hasoon J, Hunt G, Kakazu J, Lee T, Kaye AM, Kaye AD, Ganti L
Health Psychol Res. 2022; 10(5):67898.
PMID: 36726477.


The present investigation is a comprehensive review regarding the use of Suvorexant for insomnia treatment. It covers the background, pathophysiology, and significance of addressing insomnia, the pharmaceutical details of Suvorexant, and its safety, efficacy, and implications in treating insomnia. We further discuss Suvorexant's role in targeting insomnia with other comorbidities.